Magic™ Membrane Protein Human GLP1R (Glucagon like peptide 1 receptor) (CAT#: MP0015F)
The glucagon-like peptide-1 receptor (GLP-1R) is a class B GPCR that is a major therapeutic target for the treatment of type 2 diabetes. The receptor is activated by the incretin peptide GLP-1 (Glucagon Like Peptide) promoting a broad range of physiological effects including glucose-dependent insulin secretion and biosynthesis, improved insulin sensitivity of peripheral tissues, preservation of β-cell mass and weight loss, all of which are beneficial in the treatment of type 2 diabetes.
- Protein Length
- Full Length
- Protein Class
- GPCR Class B
- Validated by SPRi
- Screening & display technologies, Structural biology, Antibody development
- Expression Systems
- Cell-free expression system in the presence of lipid vesicles
- Histidine tag fused to the N-terminal end of the protein
- Protein Format
- Sucrose gradient
- >50% by SDS-Page and Coomassie Blue staining
- Store at +4°C for up to one week or several months at -80°C
- Full Name
- Glucagon like peptide 1 receptor
- This gene encodes a 7-transmembrane protein that functions as a receptor for glucagon-like peptide 1 (GLP-1) hormone, which stimulates glucose-induced insulin secretion. This receptor, which functions at the cell surface, becomes internalized in response to GLP-1 and GLP-1 analogs, and it plays an important role in the signaling cascades leading to insulin secretion. It also displays neuroprotective effects in animal models. Polymorphisms in this gene are associated with diabetes. The protein is an important drug target for the treatment of type 2 diabetes and stroke. Alternative splicing of this gene results in multiple transcript variants.
- Alternative Names
- GLP-1, GLP-1R, GLP-1-R
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.